After buying the pharma giant’s Kenilworth campus, Onyx Equities is looking to make the spot a go-to biotech hub.While much of corporate America rethinks its investment in physical offices, biotechnology companies are still wedded to laboratories and research facilities.Onyx Equities, which earlier this year bought Merck & Co.’s former Kenilworth, New Jersey headquarters, is counting […]

Author